We recently identified unique processing patterns at the C-terminal ends of circulating homodimers of apolipoprotein-A2 (apolipoprotein-A2 isoform, apoA2-i) in patients with pancreatic cancer and high-risk individuals (HRIs) [5]. Here, APOA2 is linked to pancreatic neoplasm.